U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.941C>T (p.Pro314Leu) AND Rett syndrome

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Jun 30, 2022
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000133281.7

Allele description

NM_001110792.2(MECP2):c.941C>T (p.Pro314Leu)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.941C>T (p.Pro314Leu)
Other names:
NM_001110792.2(MECP2):c.941C>T; p.Pro314Leu
HGVS:
  • NC_000023.11:g.154030923G>A
  • NG_007107.3:g.111181C>T
  • NM_001110792.2:c.941C>TMANE SELECT
  • NM_001316337.2:c.626C>T
  • NM_001369391.2:c.626C>T
  • NM_001369392.2:c.626C>T
  • NM_001369393.2:c.626C>T
  • NM_001369394.2:c.626C>T
  • NM_001386137.1:c.236C>T
  • NM_001386138.1:c.236C>T
  • NM_001386139.1:c.236C>T
  • NM_004992.4:c.905C>T
  • NP_001104262.1:p.Pro314Leu
  • NP_001303266.1:p.Pro209Leu
  • NP_001356320.1:p.Pro209Leu
  • NP_001356321.1:p.Pro209Leu
  • NP_001356322.1:p.Pro209Leu
  • NP_001356323.1:p.Pro209Leu
  • NP_001373066.1:p.Pro79Leu
  • NP_001373067.1:p.Pro79Leu
  • NP_001373068.1:p.Pro79Leu
  • NP_004983.1:p.Pro302Leu
  • NP_004983.1:p.Pro302Leu
  • LRG_764t1:c.941C>T
  • LRG_764t2:c.905C>T
  • AJ132917.1:c.905C>T
  • LRG_764:g.111181C>T
  • LRG_764p1:p.Pro314Leu
  • LRG_764p2:p.Pro302Leu
  • NC_000023.10:g.153296374G>A
  • NC_000023.10:g.153296374G>A
  • NG_007107.2:g.111205C>T
  • NM_001110792.1:c.941C>T
  • NM_004992.3:c.905C>T
  • P51608:p.Pro302Leu
Protein change:
P209L
Links:
UniProtKB: P51608#VAR_018208; dbSNP: rs61749723
NCBI 1000 Genomes Browser:
rs61749723
Molecular consequence:
  • NM_001110792.2:c.941C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386137.1:c.236C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386138.1:c.236C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386139.1:c.236C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.905C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Rett syndrome (RTT)
Synonyms:
Autism, dementia, ataxia, and loss of purposeful hand use; Rett's disorder
Identifiers:
MONDO: MONDO:0010726; MedGen: C0035372; Orphanet: 3095; Orphanet: 778; OMIM: 312750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000188289RettBASE
no assertion criteria provided
Uncertain significance
(Jan 21, 2008)
de novo, unknowncuration

PubMed (2)
[See all records that cite these PMIDs]

SCV000537170Molecular Diagnostics Lab, Nemours Children's Health, Delaware
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 30, 2015)
de novoclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV002540711ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
reviewed by expert panel

(ClinGen RettAS ACMG Specifications V2)
Pathogenic
(Jun 30, 2022)
germlinecuration

Citation Link,

SCV004232210Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Jan 9, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration
not providedunknownyes4not providednot provided4Nocuration
not providedunknownunknown1not providednot provided1not providedcuration
not providedde novoyes2not providednot provided1Noclinical testing, curation

Citations

PubMed

MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern.

Nielsen JB, Henriksen KF, Hansen C, Silahtaroglu A, Schwartz M, Tommerup N.

Eur J Hum Genet. 2001 Mar;9(3):178-84.

PubMed [citation]
PMID:
11313756

Spectrum of MECP2 mutations in Rett syndrome.

Bienvenu T, Villard L, De Roux N, Bourdon V, Fontes M, Beldjord C, Tardieu M, Jonveaux P, Chelly J; French Consortium for MECP2 Gene Analysis..

Genet Test. 2002 Spring;6(1):1-6.

PubMed [citation]
PMID:
12180070
See all PubMed Citations (9)

Details of each submission

From RettBASE, SCV000188289.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedcuration PubMed (2)
2not provided1not providedNocuration PubMed (2)
3not provided1not providednot providedcuration PubMed (2)
4not provided1not providedNocuration PubMed (2)
5not provided1not providednot providedcuration PubMed (2)
6not provided1not providednot providedcuration PubMed (2)

Description

Not known

Rett syndrome - classical

Rett syndrome - Classical

Rett syndrome - Not certain

"Rett syndrome - not certain"
"Rett syndrome - Classical"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknown1bloodnot provided1not providednot providednot provided
2de novoyes1blood or fibroblastsnot provided1not providednot providednot provided
3unknownyes1not providednot provided1not providednot providednot provided
4unknownyes1Bloodnot provided1not providednot providednot provided
5unknownyes1bloodnot provided1not providednot providednot provided
6unknownyes1Blood or skinnot provided1not providednot providednot provided

From Molecular Diagnostics Lab, Nemours Children's Health, Delaware, SCV000537170.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

From ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel, SCV002540711.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.905C>T p.(Pro302Leu) variant in MECP2 (NM_004992.3) is absent from gnomAD (PM2_supporting). The p.(Pro302Leu) variant has been observed in at least 5 individuals with Rett syndrome or severe neonatal encephalopathy (PMID: 10767337, 30377382, 23696494, 11313756, 16473305, 32472557) (PS4, PP4), where it has been reported as a de novo occurrence (biological parentage unconfirmed) in at least 4 of these individuals (PMID: 10767337, 30377382, 23696494, 11313756) (PM6_very strong). The p.(Pro302Leu) variant occurs in the well-characterized transcriptional repression domain (TRD: aa 302-306) of the MECP2 gene (PM1). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). Multiple pathogenic missense variants have been previously identified within this codon which indicates that this residue is critical to the function of the protein (PMID: 10814718, 10814719, 10944854, 17387578, 15737703) (PM5). In summary, the c.905C>T p.(Pro302Leu) variant in MECP2 is classified as Pathogenic for Rett syndrome based on the ACMG/AMP criteria (PM6_very strong, PS4, PM1, PM5, PP3, PP4, PM2_supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre for Population Genomics, CPG, SCV004232210.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: This variant is absent from gnomAD (PM2_Supporting). This variant has been identified as a de novo occurrence in at least an individual with Rett syndrome without confirmation of paternity and maternity (PM6) PMID: 10767337, ClinVar Variation ID: 143738 Has been observed in at least 5 individuals with phenotypes consistent with MECP2-related disease (PS4, PP4). (PMID: 16473305 , ClinVar Variation ID: 143738) Occurs in the well-characterized Transcriptional repression domain (TRD) of MECP2 (PM1). Computational prediction analysis tools suggests a deleterious impact (REVEL score>= 0.75) (PP3).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024